J. Hardy and D. Selkoe, The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, Science, vol.297, issue.5580, pp.353-356, 2002.
DOI : 10.1126/science.1072994

P. Klinge, A. Samii, S. Niescken, T. Brinker, and G. Silverberg, Brain amyloid accumulates in aged rats with kaolin-induced hydrocephalus, NeuroReport, vol.17, issue.6, pp.657-660, 2006.
DOI : 10.1097/00001756-200604240-00020

J. Cirrito, P. May, O. Dell, M. Taylor, J. Parsadanian et al., In vivo assessment of brain interstitial fluid with microdialysis reveals plaqueassociated changes in amyloid-beta metabolism and half-life, J Neurosci, vol.23, pp.8844-8853, 2003.

K. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten et al., Decreased Clearance of CNS ??-Amyloid in Alzheimer's Disease, Science, vol.330, issue.6012, p.1774, 2010.
DOI : 10.1126/science.1197623

G. Silverberg, M. Mayo, T. Saul, E. Rubenstein, and D. Mcguire, Alzheimer's disease, normal???pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis, The Lancet Neurology, vol.2, issue.8, pp.506-511, 2003.
DOI : 10.1016/S1474-4422(03)00487-3

K. Ono, M. Noguchi, Y. Matsumoto, D. Yanase, K. Iwasa et al., Cerebrospinal fluid of Alzheimer patients promotes ??-amyloid fibril formation in vitro, Neurobiology of Disease, vol.20, issue.2, pp.233-240, 2005.
DOI : 10.1016/j.nbd.2005.03.005

T. Ikeda, K. Ono, D. Elashoff, M. Condron, M. Noguchi-shinohara et al., Cerebrospinal Fluid from Alzheimer's Disease Patients Promotes Amyloid ??-Protein Oligomerization, Journal of Alzheimer's Disease, vol.21, issue.1, pp.81-86, 2010.
DOI : 10.3233/JAD-2010-100075

G. Silverberg, M. Miller, J. Machan, C. Johanson, I. Caralopoulos et al., Amyloid and Tau accumulate in the brains of aged hydrocephalic rats, Brain Research, vol.1317, pp.286-296, 2010.
DOI : 10.1016/j.brainres.2009.12.065

R. Adams, C. Fisher, S. Hakim, R. Ojemann, and W. Sweet, Symptomatic occult hydrocephalus with"normal " cerebrospinal fluid pressure. A treatable syndrome, N Engl J Med, vol.273, pp.1117-1126, 1965.

C. May, J. Kaye, J. Atack, M. Schapiro, R. Friedland et al., Cerebrospinal fluid production is reduced in healthy aging, Neurology, vol.40, issue.3, Part 1, pp.500-503, 1990.
DOI : 10.1212/WNL.40.3_Part_1.500

O. Baledent, C. Gondry-jouet, S. Stoquart-elsankari, R. Bouzerar, L. Gars et al., Value of phase contrast magnetic resonance imaging for investigation of cerebral hydrodynamics, Journal of Neuroradiology, vol.33, issue.5, pp.292-303, 2006.
DOI : 10.1016/S0150-9861(06)77287-X

M. Sjögren, H. Vanderstichele, H. Agren, O. Zachrisson, M. Edsbagge et al., Tau and A?42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values, Clin Chem, vol.47, pp.1776-1781, 2001.

H. Reiber, Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics, Restor Neurol Neurosci, vol.21, pp.79-96, 2003.

C. Johanson, Ventricles and cerebrospinal fluid, Neuroscience in Medicine, pp.171-196

Y. Ingenbleek and V. Young, Transthyretin (Prealbumin) in Health and Disease: Nutritional Implications, Annual Review of Nutrition, vol.14, issue.1, pp.495-533, 1994.
DOI : 10.1146/annurev.nu.14.070194.002431

H. Lins, I. Wichart, C. Bancher, C. Wallesch, K. Jellinger et al., Immunoreactivities of amyloid ? peptide(1?42) and total ? protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus, Journal of Neural Transmission, vol.111, issue.3, pp.273-280, 2004.
DOI : 10.1007/s00702-003-0075-x

A. Tarnaris, L. Watkins, and N. Kitchen, Biomarkers in chronic adult hydrocephalus, Cerebrospinal Fluid Research, vol.3, issue.1, p.11, 2006.
DOI : 10.1186/1743-8454-3-11

A. Agren-wilsson, A. Lekman, W. Sjöberg, L. Rosengren, K. Blennow et al., CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus, Acta Neurologica Scandinavica, vol.21, issue.5, pp.333-339, 2007.
DOI : 10.1046/j.1351-5101.2003.00698.x

E. Kapaki, G. Paraskevas, N. Tzerakis, C. Sfagos, A. Seretis et al., in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease, European Journal of Neurology, vol.68, issue.3, pp.168-177, 2007.
DOI : 10.1016/S0197-4580(98)00022-0

M. Tisell, M. Tullberg, J. Mansson, P. Fredman, K. Blennow et al., Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus, European Journal of Neurology, vol.31, issue.373, pp.17-23, 2004.
DOI : 10.1016/0022-3956(88)90030-1

C. Stenh, H. Englund, A. Lord, A. Johansson, C. Almeida et al., Amyloid-?? oligomers are inefficiently measured by enzyme-linked immunosorbent assay, Annals of Neurology, vol.1, issue.1, pp.147-150, 2005.
DOI : 10.1002/ana.20524

V. Shuvaev, I. Laffont, J. Serot, J. Fujii, N. Taniguchi et al., Increased protein glycation in cerebrospinal fluid of Alzheimer's disease, Neurobiology of Aging, vol.22, issue.3, pp.397-402, 2001.
DOI : 10.1016/S0197-4580(00)00253-0

M. Otto, H. Esselmann, W. Schulz-shaeffer, M. Neumann, A. Schröter et al., Decreased ??-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, Neurology, vol.54, issue.5, pp.1099-1102, 2000.
DOI : 10.1212/WNL.54.5.1099

E. Parkin, N. Watt, I. Hussain, E. Eckman, C. Eckman et al., Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein, Proceedings of the National Academy of Sciences, vol.104, issue.26, pp.11062-11067, 2007.
DOI : 10.1073/pnas.0609621104

D. Strozyk, K. Blennow, L. White, and L. Launer, CSF A?? 42 levels correlate with amyloid-neuropathology in a population-based autopsy study, Neurology, vol.60, issue.4, pp.652-656, 2003.
DOI : 10.1212/01.WNL.0000046581.81650.D0

W. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist et al., Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Annals of Neurology, vol.107, issue.suppl 1, pp.306-319, 2004.
DOI : 10.1002/ana.20009

A. Fagan, M. Mintun, R. Mach, S. Lee, C. Dence et al., in humans, Annals of Neurology, vol.111, issue.3, pp.512-519, 2006.
DOI : 10.1002/ana.20730

T. Grimmer, M. Riemenschneider, H. Förstl, G. Henriksen, W. Klunk et al., Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid, Biological Psychiatry, vol.65, issue.11, pp.927-934, 2009.
DOI : 10.1016/j.biopsych.2009.01.027

V. Leinonen, I. Alafuzoff, S. Aalto, T. Suotunen, S. Savolainen et al., Assessment of ??-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11???Labeled Pittsburgh Compound B, Archives of Neurology, vol.65, issue.10, pp.1304-1309, 2008.
DOI : 10.1001/archneur.65.10.noc80013

V. Leinonen, A. Koivisto, S. Savolainen, J. Rummukainen, J. Tamminen et al., Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease, Annals of Neurology, vol.7, issue.4, pp.446-53, 2010.
DOI : 10.1002/ana.22100

J. Golomb, J. Wisoff, D. Miller, I. Boksay, A. Kluger et al., Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response, Journal of Neurology, Neurosurgery & Psychiatry, vol.68, issue.6, pp.778-781, 2000.
DOI : 10.1136/jnnp.68.6.778

G. Silverberg, A. Messier, M. Miller, J. Machan, S. Majmudar et al., Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging, Journal of Neuropathology & Experimental Neurology, vol.69, issue.10, pp.1034-1043, 2010.
DOI : 10.1097/NEN.0b013e3181f46e25

E. Hellström-lindahl, R. Ravid, and A. Nordberg, Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with A?? levels, Neurobiology of Aging, vol.29, issue.2, pp.210-221, 2008.
DOI : 10.1016/j.neurobiolaging.2006.10.010

B. Ott, R. Cohen, A. Gongvatana, O. Okonkwo, C. Johanson et al., Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease, Journal of Alzheimer's Disease, vol.20, issue.2, pp.647-657, 2010.
DOI : 10.3233/JAD-2010-1406